Torrent Pharmaceuticals Limited — Board Meeting, 13-02-2026: Outcome of Board Meeting
13-02-2026 | 05:00 pm
13-02-2026 | 05:00 pm
Torrent Pharma's board approved Q3 consolidated financial results: Revenue jumped 18% to ₹3,303 Cr, Net Profit surged 26% to ₹635 Cr. An interim dividend of ₹29/share was also approved. The company has completed acquiring a 48.8% stake in JB Pharma, with a merger scheme underway.
No comments yet. Be the first to comment!
